PepGen Inc.
- PEPG
- NASDAQ
- Biotechnology
- Oligonucleotide Therapeutics
- Neuromuscular Disease Drugs
$2.63
Today +0.96%Quote Oct 19, 2026, 05:00 PM UTC
−12.46%over the last month
Max drawdown −25.8%From 1-month high −12.8%3 months +18.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About PepGen
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
57
Founded
2018
Market value
$181.6M
Quote Oct 19
Analyst target
$4.00
+52.4% from here
Floor
$2.51
4.4% below price
Resistance
$2.76
5.1% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PEPGPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free